Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PAUL D LYONS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Clinical Neurophysiology

NPI
1083656250
CMS profile
4126
Location
WINCHESTER, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$15,099.93

152 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PAUL D LYONS

NPI 1083656250 · CMS profile ID 4126

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Clinical Neurophysiology

WINCHESTER, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1083656250?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PAUL D LYONS, NPI 1083656250, CMS profile ID 4126. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1083656250?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). PAUL D LYONS, NPI 1083656250, CMS profile ID 4126. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1083656250?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
PAUL D LYONS, NPI 1083656250, CMS profile ID 4126, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1083656250?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

152 matching records · $15,099.93 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 152 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 152.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $0.6508/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229286615 CMS
Inspire Medical Systems, Inc. $87.8208/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251485425 CMS
TG Therapeutics, Inc. $27.2008/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226245169 CMS
Eisai Inc. $14.5208/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244504290 CMS
Eisai Inc. $0.3108/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244504292 CMS
JAZZ PHARMACEUTICALS INC. $25.8707/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234327970 CMS
ABBVIE INC. $16.5307/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202338412 CMS
PFIZER INC. $20.6707/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228985769 CMS
Genentech USA, Inc. $21.8507/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211565329 CMS
UCB, Inc. $15.2507/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224544944 CMS
Merz Pharmaceuticals, LLC $19.5407/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232565886 CMS
Neurelis, Inc. $10.1207/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219195015 CMS
PFIZER INC. $5.0007/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229021617 CMS
Abbott Laboratories $21.4707/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240722510 CMS
Biogen, Inc. $22.1807/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208430774 CMS
BIOCODEX, INC. $20.2807/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1254624176 CMS
GE HEALTHCARE $13.8706/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244295438 CMS
ARGENX US, INC. $25.6006/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240444007 CMS
UCB, Inc. $1,000.0006/26/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1224544942 CMS
CATALYST PHARMACEUTICALS, INC. $25.5306/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1253225287 CMS
ABBVIE INC. $14.4006/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202338410 CMS
Teva Pharmaceuticals USA, Inc. $17.4506/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247360658 CMS
PFIZER INC. $1.8406/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230122027 CMS
Lilly USA, LLC $0.6606/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186811625 CMS
Lilly USA, LLC $21.8206/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186813349 CMS
PFIZER INC. $21.0306/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228940787 CMS
ABBVIE INC. $29.7306/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202338408 CMS
Neurelis, Inc. $78.1406/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219195013 CMS
UCB, Inc. $17.1306/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224544940 CMS
SK Life Science, Inc. $22.9406/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252283653 CMS
GE HEALTHCARE $25.7806/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244292007 CMS
GE HEALTHCARE $25.7706/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244292617 CMS
PFIZER INC. $6.3406/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228907096 CMS
Alexion Pharmaceuticals, Inc. $20.5906/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202963094 CMS
Eisai Inc. $0.2406/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244504284 CMS
Eisai Inc. $0.2106/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244504288 CMS
Eisai Inc. $13.0305/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244504286 CMS
Neurelis, Inc. $13.1205/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219195011 CMS
Tanabe Pharma America, Inc. $29.7605/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243920717 CMS
UCB, Inc. $840.0005/23/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1224544938 CMS
Neurelis, Inc. $124.1305/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219195009 CMS
E.R. Squibb & Sons, L.L.C. $32.0005/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184525124 CMS
UCB, Inc. $11.2005/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224544936 CMS
Neurelis, Inc. $10.2605/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219195007 CMS
PFIZER INC. $23.7105/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231726376 CMS
TG Therapeutics, Inc. $27.9505/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226245086 CMS
SK Life Science, Inc. $33.3805/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252283645 CMS
UCB, Inc. $7.0305/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224544934 CMS
JAZZ PHARMACEUTICALS INC. $1,470.0004/30/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234300214 CMS
Genentech USA, Inc. $20.0204/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211565326 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $28,933.30 188
PY2020 $28,268.11 98
PY2021 $23,665.38 109
PY2022 $24,198.68 166
PY2023 $21,167.34 212
PY2024 $30,100.89 216
PY2025 $15,099.93 152

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $85,422.66 28
PY2024 Principal investigator $32,085.22 24
PY2023 Principal investigator $55,416.19 23
PY2022 Principal investigator $16,486.76 10
PY2021 Principal investigator $32,409.75 9
PY2020 Principal investigator $50,753.47 10
PY2019 Principal investigator $261,287.22 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

28 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $3,750.00 12/24/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295030
Principal investigator 1 Janssen Research & Development, LLC $2,275.00 12/17/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295011
Principal investigator 1 SK Life Science, Inc. $2,500.00 12/02/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274997
Principal investigator 1 SK Life Science, Inc. $500.00 12/02/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274999
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $50.00 11/26/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745766
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $563.35 11/26/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745770
Principal investigator 1 Janssen Research & Development, LLC $6,200.00 11/14/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295151
Principal investigator 1 Janssen Research & Development, LLC $600.00 10/20/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295064
Principal investigator 1 Janssen Research & Development, LLC $1,000.00 10/06/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295073
Principal investigator 1 UCB SA $6,500.00 09/24/2025 Non-covered Recipient Entity
Valley Health Diabetes Management Program
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of Staccato alprazolam in STUDY participants 12 years of age and older with stereotypical prolonged seizures No dispute reported 06/30/2026 1246658240
Principal investigator 1 UCB SA $6,500.00 09/22/2025 Non-covered Recipient Entity
Valley Health Diabetes Management Program
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, OUTPATIENT, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF STACCATO ALPRAZOLAM IN STUDY PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH STEREOTYPICAL PROLONGED SEIZURES No dispute reported 06/30/2026 1246658238
Principal investigator 1 Janssen Research & Development, LLC $7,525.00 09/19/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295167
Principal investigator 1 SK Life Science, Inc. $850.00 09/09/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274995
Principal investigator 1 Janssen Research & Development, LLC $1,168.00 09/03/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295182
Principal investigator 1 Janssen Research & Development, LLC $4,950.00 07/28/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295160
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $563.35 07/23/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745774
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $400.00 07/07/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745768
Principal investigator 1 UCB SA $5,593.79 06/16/2025 Non-covered Recipient Entity
WINCHESTER NEUROLOGICAL CONSULTANTS
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of Staccato alprazolam in STUDY participants 12 years of age and older with stereotypical prolonged seizures No dispute reported 06/30/2026 1246658246
Principal investigator 1 UCB SA $145.89 06/16/2025 Non-covered Recipient Entity
WINCHESTER NEUROLOGICAL CONSULTANTS
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, OUTPATIENT, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF STACCATO ALPRAZOLAM IN STUDY PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH STEREOTYPICAL PROLONGED SEIZURES No dispute reported 06/30/2026 1246658996
Principal investigator 1 Janssen Research & Development, LLC $4,975.00 06/13/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295140
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,322.68 05/21/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745776
Principal investigator 1 Janssen Research & Development, LLC $3,750.00 05/16/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295038
Principal investigator 1 Janssen Research & Development, LLC $1,875.00 03/19/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295196
Principal investigator 1 Janssen Research & Development, LLC $1,560.00 02/19/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295099
Principal investigator 1 SK Life Science, Inc. $8,475.00 02/18/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274993
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $3,651.00 01/30/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745772
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,339.60 01/30/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745778
Principal investigator 1 Janssen Research & Development, LLC $6,840.00 01/17/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175294986